Dizal Pharmaceutical (688192.SH) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Oct30

Dizal Pharmaceutical released FY2025 9 Months earnings on October 30 After-Market (BJT), actual revenue CNY 586.3 M, actual EPS CNY -1.3213

01:00

Dizal Pharmaceutical released FY2025 Q3 earnings on October 30 After-Market (BJT), actual revenue CNY 231.3 M, actual EPS CNY -0.4496

01:00

Oct23

Dizal Pharmaceutical to Release FY2025 Q3 Earnings on October 31 After-Market BJT

01:02

Aug22

Dizal Pharmaceutical released FY2025 Q2 earnings on August 22 After-Market (BJT), actual revenue CNY 195.36 M, actual EPS CNY -0.4116

01:00

Dizal Pharmaceutical released FY2025 Semi-Annual Earnings on August 22 After-Market BJT, actual revenue CNY 355 M, actual EPS CNY -0.87

01:00

Aug21

Dizal Pharmaceutical to Release FY2025 Semi-Annual Earnings on August 29, 2025 (BJT)

00:31

Schedules & Filings

Schedules

Filings

Oct30

Earning Release(CST)

FY2025 Q3 Earning Release (CNY) Revenue 231.3 M, Net Income -202.59 M, EPS -0.4496

Aug29

Earning Release(CST)

FY2025 Semi-Annual Earning Release

Aug22

Earning Release(CST)

FY2025 Q2 Earning Release (CNY) Revenue 195.36 M, Net Income -184.85 M, EPS -0.4116

View More

Stock List

Top Gainers

Top Decliners

Northbound Connect

Symbol

Price

%Chg

Change

View More